Ark Therapeutics Group PLC Holding(s) in Company (1174P)
September 27 2013 - 5:46AM
UK Regulatory
TIDMAKT
RNS Number : 1174P
Ark Therapeutics Group PLC
27 September 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or the underlying Ark Therapeutics Group Plc
issuer
of existing shares to which voting rights
are
attached: (ii)
------------------------------------------------ ----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
--------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
--------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------- -------
Other (please
specify):
------------------ ------------------------------------------------------- -------
3. Full name of person(s) subject Winterflood Securities Limited
to the
notification obligation: (iii)
------------------------------------------ ----------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):(iv)
------------------------------------------ ----------------------------------------
5. Date of the transaction and date 25(th) September 2013
on
which the threshold is crossed
or
reached: (v)
------------------------------------------ ----------------------------------------
6. Date on which issuer notified: 26(h) September 2013
------------------------------------------ ----------------------------------------
7. Threshold(s) that is/are crossed Below 10%
or
reached: (vi, vii)
------------------------------------------ ----------------------------------------
8. Notified details:
---------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
---------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------- --------------------------------- -----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
--------------- ------------- ------------------ ----------- ------------------------ --------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ---- ------- ------ ----- --- ----------- ------------- --------- -------------- ----------
GB0034251727 20,931,350 20,931,350 19,060,944 19,060,944 - Below 10% -
------------- ------------------ ----------- ------------- --------- -------------- ----------
B: Qualifying Financial Instruments
---------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
--------------------- --------------- ---------------------------- ---------------------------- -----------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
---------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
--------------- ------------- ------------- ---------------- ----------------------------- ---------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ----------------------------- ---------- ---------
Total (A+B+C)
---------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------------------- ----------------------------------------------------
19,060,944 Below 10%
--------------------------------------------------------------- ----------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
--------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: Daniel Demirel
---------------------------------------- --------------------------------------
15. Contact telephone number: 020 3100 0000
---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBSRROOAKUAR
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Premier Veterinary Group Plc (London Stock Exchange): 0 recent articles
More ARK Therapeutics News Articles